Globe Life Inc. $GL Shares Sold by Geneos Wealth Management Inc.

Geneos Wealth Management Inc. trimmed its position in Globe Life Inc. (NYSE:GL) by 46.4% in the 1st quarter, HoldingsChannel reports. The firm owned 3,277 shares of the company’s stock after selling 2,835 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Globe Life were worth $456,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. SG Americas Securities LLC raised its holdings in shares of Globe Life by 909.6% during the 4th quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock worth $13,950,000 after acquiring an additional 89,866 shares during the period. Tudor Investment Corp ET AL purchased a new stake in shares of Globe Life in the third quarter valued at about $7,348,000. JPMorgan Chase & Co. grew its holdings in shares of Globe Life by 11.1% in the third quarter. JPMorgan Chase & Co. now owns 247,947 shares of the company’s stock valued at $35,449,000 after purchasing an additional 24,785 shares during the period. Jupiter Asset Management Ltd. acquired a new stake in Globe Life during the fourth quarter worth about $2,073,000. Finally, Northwestern Mutual Wealth Management Co. increased its position in Globe Life by 34,786.0% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after purchasing an additional 879,391 shares during the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Insider Transactions at Globe Life

In other Globe Life news, EVP Michael Clay Majors sold 34,000 shares of the business’s stock in a transaction that occurred on Friday, April 24th. The stock was sold at an average price of $153.81, for a total value of $5,229,540.00. Following the sale, the executive vice president owned 53,518 shares of the company’s stock, valued at $8,231,603.58. The trade was a 38.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Cheryl Alston sold 8,258 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the completion of the sale, the director directly owned 16,621 shares in the company, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 124,187 shares of company stock worth $19,529,414 in the last three months. Company insiders own 2.11% of the company’s stock.

Globe Life Trading Down 0.1%

Shares of GL stock opened at $184.55 on Tuesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The firm has a market cap of $14.33 billion, a PE ratio of 12.76 and a beta of 0.47. The company has a 50-day moving average of $167.16 and a two-hundred day moving average of $151.92. Globe Life Inc. has a 1-year low of $120.05 and a 1-year high of $191.55.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The company had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. Globe Life’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, analysts predict that Globe Life Inc. will post 15.64 EPS for the current year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. Globe Life’s dividend payout ratio (DPR) is presently 9.13%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Piper Sandler raised their price target on shares of Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a report on Wednesday, July 15th. Truist Financial lifted their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. TD Cowen upped their price objective on Globe Life from $199.00 to $215.00 and gave the company a “buy” rating in a report on Tuesday, June 23rd. Finally, Keefe, Bruyette & Woods increased their price objective on Globe Life from $180.00 to $192.00 and gave the stock an “outperform” rating in a research report on Monday, July 13th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $184.60.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.